Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,574 | 192,198 | 154,806 | 170,233 | 243,592 |
| Receivables | 190,101 | 212,872 | 209,888 | 211,095 | 210,214 |
| Inventories | 102,723 | 100,290 | 96,403 | 97,560 | 96,882 |
| Other current assets | 120,203 | 61,003 | 108,608 | 102,832 | 67,451 |
| TOTAL | $595,601 | $566,363 | $569,705 | $581,720 | $618,139 |
| Non-Current Assets | |||||
| PPE Net | 863,744 | 863,786 | 857,517 | 834,545 | 837,246 |
| Intangibles | 661,815 | 675,032 | 632,182 | 581,684 | 593,678 |
| Other Non-Current Assets | 82,933 | 86,351 | 94,214 | 89,639 | 92,350 |
| TOTAL | $1,608,492 | $1,625,169 | $1,583,913 | $1,505,868 | $1,523,274 |
| Total Assets | $2,204,093 | $2,191,532 | $2,153,618 | $2,087,588 | $2,141,413 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,413 | 34,594 | 35,404 | 35,376 | 35,452 |
| Accounts payable and accrued liabilities | 31,218 | 35,843 | 36,568 | 37,280 | 40,517 |
| Accrued Expenses | 94,046 | 92,825 | 101,763 | 96,592 | 115,611 |
| Other current liabilities | 15,219 | 17,421 | 20,980 | 26,889 | 22,711 |
| TOTAL | $249,773 | $254,099 | $269,645 | $279,873 | $300,998 |
| Non-Current Liabilities | |||||
| Long Term Debt | 457,419 | 463,748 | 486,487 | 474,152 | 479,880 |
| Deferred Revenues | 71,114 | 73,416 | 74,930 | 83,689 | 86,707 |
| Other Non-Current Liabilities | 123,559 | 124,833 | 115,029 | 116,061 | 119,178 |
| TOTAL | $580,496 | $588,259 | $601,017 | $589,677 | $598,707 |
| Total Liabilities | $830,269 | $842,358 | $870,662 | $869,550 | $899,705 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,888 | 65,897 | 65,894 | 66,098 | 66,790 |
| Common Shares | 771 | 771 | 771 | 771 | 766 |
| Retained earnings | -238,493 | -256,062 | -293,375 | -327,531 | -352,934 |
| Other shareholders' equity | 44,091 | 42,218 | 19,781 | -19,070 | 3,845 |
| TOTAL | $1,373,824 | $1,349,174 | $1,282,956 | $1,218,038 | $1,241,708 |
| Total Liabilities And Equity | $2,204,093 | $2,191,532 | $2,153,618 | $2,087,588 | $2,141,413 |